BioLight Reports Positive Second Clinical Study Results for its TeaRx™ Multi-Assay Test for Dry Eye Syndrome

BioLight announced today the completion of a successful U.S. clinical study that was designed to assess the effectiveness of its TeaRx™ multi-assay test in evaluating tears’ components of healthy subjects as well as of patients suffering from dry eye syndrome.

Link to complete article

Link to Newsroom

Comments are closed.